Heart Failure - PARAGLIDE-HF

A MULTICENTER, RANDOMZIED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, ACTIVE CONTROLLED 8-WEEK STUDY TO EVALUATE THE EFFECT OF SACUBITRIL/VALSARTAN VERSUS VALSARTAN ALONE ON CHANGES IN NT-proBNP.

Dr. Jaiswal and the Heart Failure Team will participate in this study investigating certain blood tests that may help identify patients that are at increased risk of death or re-hospitalized again after discharge.  This blood test will reflect elevated pressures or stress on the heart to help identify patients at higher risk. 

ELIGIBILITY CRITERIA

  • Patients currently hospitalized with acute Heart Failure

Please contact Khadija El Aoudi at 860-972-3167 or by email at Khadija.elaoudi@hhchealth.org for more information